Chemical Compound

GSK-F1

CAS Registry Number 1402345-92-9
GSK-F1 chemical structure
Primary Record

GSK-F1

In stock
3,159 g
Purity
98.9 %
CAS
1402345-92-9

Compound Identifiers & Properties

CAS
1402345-92-9
PubChem CID
57406702
SMILES
COC1=C(C=C(C=N1)C2=CC3=C(C=C2)N=C(N(C3=O)C4=CC=CC=C4C(F)(F)F)N)S(=O)(=O)NC5=C(C=C(C=C5)F)F
Canonical SMILES
COc1ncc(-c2ccc3nc(N)n(-c4ccccc4C(F)(F)F)c(=O)c3c2)cc1S(=O)(=O)Nc1ccc(F)cc1F

Names & Synonyms

  • GSK-F1
  • PI4KA inhibitor-F1
  • 1402345-92-9
  • 1384097-27-1
  • 5-(2-amino-4-oxo-3-(2-(trifluoromethyl)phenyl)-3,4-dihydroquinazolin-6-yl)-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide
  • (S)-GSK-F1
  • C27H18F5N5O4S
  • CHEMBL3121308
  • GSK-F1?
  • orb1306848
  • orb1685569
  • SCHEMBL9953714
  • SCHEMBL30089020
  • SCHEMBL31722834
  • SYN1220
  • MFCD29770785
  • MSRFVAYVUUHQCN-UHFFFAOYSA-N
  • GLXC-07612
  • AMY40907
  • BCP29575
  • BCP34465
  • EX-A1702
  • BDBM50448077
  • NSC804572
  • AKOS030530471
  • ZINC103264410
  • HY-100603A
  • NSC-804572
  • AC-36203
  • AS-16346
  • DA-56850
  • 1384097-27-1 pound>>rac-GSK-F1
  • DB-212889
  • HY-100603
  • CS-0019756
  • CS-1097310
  • H20651
  • A886246
  • A900425
  • 5-[2-amino-4-oxo-3-[2-(trifluoromethyl)phenyl]quinazolin-6-yl]-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide
  • 3-Pyridinesulfonamide, 5-[2-amino-3,4-dihydro-4-oxo-3-[2-(trifluoromethyl)phenyl]-6-quinazolinyl]-N-(2,4-difluorophenyl)-2-methoxy-
  • 5-{2-amino-4-oxo-3-[2-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-6-yl}-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide
  • 5-((3S)-2-Amino-4-oxo-3-(2-(trifluoromethyl)phenyl)-3,4-dihydroquinazolin-6-yl)-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide
  • 5-[2-amino-4-oxo-3-[2-(trifluoromethyl)phenyl]quinazolin-6-yl]-N-(2,4-difluorophenyl)-2-methoxy-pyridine-3-sulfonamide
  • 5-{2-AMINO-4-OXO-3-[2-(TRIFLUOROMETHYL)PHENYL]QUINAZOLIN-6-YL}-N-(2,4-DIFLUOROPHENYL)-2-METHOXYPYRIDINE-3-SULFONAMIDE